ArticleBlood cancer journal2014

Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.

P Miltiades et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.